Results
1
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
1 companies
Vytrus Biotech
Market Cap: €135.3m
Vytrus Biotech, S.A. desarrolla, produce y comercializa principios activos a partir de células madre vegetales en España y a escala internacional.
VYT
€18.00
7D
3.4%
1Y
267.3%